Novartis Pediatric Triaminic Target Of Proposed Class Action
This article was originally published in The Tan Sheet
Executive Summary
Novartis' Triaminic Daytime Cold & Cough, one of the OTC children's cold product lines voluntarily withdrawn from the market in 2007 due to concerns about misuse, is the subject of proposed class action